Breast Cancer Research and Treatment

, Volume 2, Issue 3, pp 251–255 | Cite as

Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer

  • S. Thoresen
  • T. Thorsen
  • M. Tangen
  • F. Hartveit
Reports

Summary

Histological grading of 160 primary infiltrating breast carcinomas showed that both oestrogen and progesterone receptor status are strongly related to grade, tumours that are receptor positive tending to be of lower grade than the receptor negative.

The nuclear factors used in grading were those that determined this association. In addition the absence/presence of both receptors was reflected in the grade present, beyond the correlation expected on the basis of either receptor alone.

Keywords

breast cancer histological grade steroid receptors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McGuire WL, Pearson OH, Segaloff A: Predicting hormone responsiveness in human breast cancer.In WL McGuire, PP Carbone, and EP Vollmer (eds): Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975, pp 17–30Google Scholar
  2. 2.
    Maynard PV, Davies CJ, Blamey RW, Elston CW, Griffiths K: Relationship between oestrogen receptor content and histological grade in human primary breast tumours. Br J Cancer 38: 745–748, 1978PubMedGoogle Scholar
  3. 3.
    Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight WA, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobsen A, Queen DM, Bennett DE, Ford HC: Correlation of primary breast cancer histopathology and estrogen receptor content. Breast Cancer Res Treat 1: 37–41, 1981PubMedGoogle Scholar
  4. 4.
    Thoresen S, Tangen M, St∅a KF, Hartveit F: Oestrogen receptor values and histological grade in human breast cancer. Histopathology 5: 257–262, 1981PubMedGoogle Scholar
  5. 5.
    King RJB: Analysis of estradiol and progesterone receptors in early and advanced breast tumours. Cancer 46: 2818–2821, 1980PubMedGoogle Scholar
  6. 6.
    Würz H, Citoler P, Schülz KD, Roos B, Kaiser R: Correlation of steroid hormone receptor levels with histological grading in human breast cancer. Klin Wschr 58: 643, 1981Google Scholar
  7. 7.
    Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359–377, 1957PubMedGoogle Scholar
  8. 8.
    Scharff RW, Torloni H: Histological typing of breast tumours. Wld Hlth Org, Geneva, 1968, No. 2, pp 17–18Google Scholar
  9. 9.
    Horwitz KB, Costlow ME, McGuire WL: MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone and glucocorticoid receptors. Steroids 26: 785–795, 1975PubMedGoogle Scholar
  10. 10.
    Thorsen T: Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem 10: 661–668, 1979PubMedGoogle Scholar
  11. 11.
    Schi∅dt T: Breast Carcinoma. A histological and prognostic study of 650 followed up cases. Munksgaard, Copenhagen, 1966Google Scholar
  12. 12.
    Bunting JS, Kremer JK: Breast cancer and histological grade. Lancet ii: 364, 1981Google Scholar
  13. 13.
    Freedman LS, Edwards DN, McConell EM, Dowham DY: Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer 40: 44–55, 1979PubMedGoogle Scholar
  14. 14.
    Thoresen S: Histological grade and clinical stage at presentation in breast carcinoma. Br J Cancer (in press)Google Scholar
  15. 15.
    Thorsen T: Occupied and unoccupied oestradiol receptor in human breast tumour cytosol. J Steroid Biochem 13: 405–408, 1980PubMedGoogle Scholar
  16. 16.
    Sarrif AM, Durant JR: Evidence that estrogen-receptornegative progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor. Cancer 48: 1215–1220, 1981PubMedGoogle Scholar
  17. 17.
    Godolphin W, Elwood JM, Sipelli JJ: Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients. Int J Cancer 28: 677–683, 1981PubMedGoogle Scholar
  18. 18.
    Horwitz KB, McGuire WL: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189: 726–727, 1975PubMedGoogle Scholar
  19. 19.
    Hartveit F, Thoresen S, Thorsen T, Tangen M: Histological grade and efferent vascular invasion in human breast carcinoma. Br J Cancer 44: 81–84, 1981PubMedGoogle Scholar
  20. 20.
    McCarty Jr KS, Banton TK, Fetter BF, Woodward BH, Mossler JA, Reeves W, Daly J, Wilkinson WE, McCarty Sr KS: Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46: 2851–2858, 1980PubMedGoogle Scholar
  21. 21.
    Stenkvist B, Westman-Naeser S, Vegelius J, Holmquist J, Nordin B, Bengtsson E, Eriksson O: Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Path 32: 979–985, 1979PubMedGoogle Scholar
  22. 22.
    Stenkvist B, Bengtsson E, Eriksson O, Jarkrans T, Nordin B, Westman-Naeser S: Correlation between cytometric features and mitotic frequency in human breast carcinoma. Cytometry 1: 287–291, 1981PubMedGoogle Scholar
  23. 23.
    Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz MK: Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology. Cancer 48: 299–309, 1981PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers 1982

Authors and Affiliations

  • S. Thoresen
    • 1
  • T. Thorsen
    • 2
  • M. Tangen
    • 3
  • F. Hartveit
    • 1
  1. 1.Department of PathologyThe Norwegian Cancer Society and The Gade InstituteNorway
  2. 2.The Hormone LaboratoryUniversity of BergenNorway
  3. 3.The Deaconess HospitalBergenNorway

Personalised recommendations